Results 121 to 130 of about 74,631 (338)

Mitigating gut microbial degradation of levodopa and enhancing brain dopamine: Implications in Parkinson’s disease

Communications Biology
Parkinson’s disease is managed using levodopa; however, as Parkinson’s disease progresses, patients require increased doses of levodopa, which can cause undesirable side effects. Additionally, the oral bioavailability of levodopa decreases in Parkinson’s
Gang Cheng, Micael Hardy, Cecilia J. Hillard, Jimmy B. Feix, Balaraman Kalyanaraman   +4 more
doaj   +1 more source

Sodium valproate in the treatment of levodopa-induced dyskinesia. [PDF]

, 1978
Paul A. Price, J. D. Parkes, C. D. Marsden   +2 more
openalex   +1 more source

The Unseen Burden: Uncovering Shame and Its Determinants in Parkinson's Disease

Movement Disorders Clinical Practice, EarlyView.
Abstract Background Shame is frequent in Parkinson's disease (PD) and often overlooked. Objective The aim was to assess factors associated with PD‐related shame. Methods PD‐related shame was measured using the Shame and Embarrassment in PD (SPARK) scale in patients without cognitive impairment.
Sabina Catalano Chiuvé, Damien Benis, Charline Rime, Maria João Forjaz, Paul Krack, Carmen Rodriguez‐Blazquez, Vanessa Fleury   +6 more
wiley   +1 more source

Incidence of Side Effects from Levodopa during the Introduction of Treatment [PDF]

, 1971
R B Godwin-Austen, C. C. Frears, S. Bergmann   +2 more
openalex   +1 more source

Freezing of gait and levodopa [PDF]

The Lancet Neurology, 2021
Gilat, Moran, D’Cruz, Nicholas, Ginis, Pieter, Vandenberghe, Wim, Nieuwboer, Alice   +4 more
openaire   +3 more sources

Compressive Cervical Myelopathy Causing Impaired Gait after Deep Brain Stimulation Is Not Rare

Movement Disorders Clinical Practice, EarlyView.
Caroline Weill, Sami Heymann, Roy Dayan, Eduard Linetsky, Hagai Bergman, Zvi Israel, David Arkadir   +6 more
wiley   +1 more source

Gender Is the Main Predictor of Wearing‐Off and Dyskinesia in Levodopa‐Naïve Patients with Parkinson's Disease

Movement Disorders Clinical Practice, EarlyView.
Abstract Background Evidence suggests that female gender represents a risk factor for the development of motor/nonmotor fluctuations and dyskinesia in Parkinson's disease (PD). So far, no prospective study has analyzed this aspect in relation to the introduction of levodopa treatment.
Maria Teresa Pellecchia, Marina Picillo, Maria Claudia Russillo, Marianna Amboni, Gennarina Arabia, Laura Avanzino, Margherita Canesi, Alessia Catania, Roberto Ceravolo, Calogero Edoardo Cicero, Roberto Cilia, Isabel Colangelo, Giovanna Dati, Rosa De Micco, Anna De Rosa, Alessio Di Fonzo, Roberto Eleopra, Vincenza Fetoni, Barbara Garavaglia, Augusta Giglio, Martina Giuntini, Federica Invernizzi, Giulia Lazzeri, Roberta Marchese, Alessandra Nicoletti, Claudio Pacchetti, Celeste Panteghini, Manuela Pilleri, Fabiana Radicati, Chiara Reale, Cesa Scaglione, Andrea Soricelli, Fabrizio Stocchi, Alessandro Tessitore, Laura Vacca, Maria Antonietta Volontè, Graziella Volpi, Roberta Zangaglia, Francesco Amato, Carlo Ricciardi, Michela Russo, Paolo Barone   +41 more
wiley   +1 more source

Interaction between Levodopa and Methyldopa [PDF]

, 1973
F B Gibberd, Eric M. Small
openalex   +1 more source

Management of Anxiety in Parkinson's Disease

Movement Disorders Clinical Practice, EarlyView.
ABSTRACT Background Anxiety is a common, distressing, hard‐to‐diagnose and hard‐to‐treat symptom in Parkinson's disease. No formal guidelines exist to assist management. Objective We provide a pragmatic guide to detecting and managing anxiety in Parkinson's disease.
Alex J. Berry, Harry Costello, Silvia Jesús, Gary Price, Ashwani Jha   +4 more
wiley   +1 more source

Letter: Levodopa in coma due to fulminant hepatitis. [PDF]

, 1975
P A Contoyiannis, E Draginis, D. A. Adamopoulos, G. Triantafyllou   +3 more
openalex   +1 more source